Associate Professor Kerwyn Foo

Clinical Associate Professor
Medicine, Central Clinical School

Telephone 02 95158057
Fax 02 95158070

Map

Biographical details

BSc - School of Physics, University of Sydney 1995

MBBS(Hons) - Faculty of Medicine, University of Sydney 1999 FRANZCR - Faculty of Radiation Oncology, Royal Australian & NZ College of Radiologists 2005 Clinical Lecturer, Nepean Clinical School, Sydney Medical School, University of Sydney 2003-6 Clinical Associate Professor, Graduate School of Medicine, University of Wollongong 2006-present Honorary Senior Fellow, Faculty of Engineering, University of Wollongong 2006-present

Research interests

Medical Physics, Radiobiology, Normal Tissue Effects of Radiation and Cancer Therapy, Clinical Oncology, Prostate Cancer, Gynaecological Oncology, Radiotherapy

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Ebert, M., Foo, K., Haworth, A., Gulliford, S., Kearvall, R., Kennedy, A., Richardson, S., Krawiec, M., Stewart, N., Joseph, D., et al (2014). Derivation and representation of dose-volume response from large clinical trial data sets: An example from the RADAR prostate radiotherapy trial. Journal of Physics: Conference Series, 489(1), Article number 012090. [More Information]
  • Ch'ng, S., Oates, J., Gao, K., Foo, K., Davies, S., Brunner, M., Clark, J. (2014). Prospective quality of life assessment between treatment groups for oral cavity squamous cell carcinoma. Head and Neck, 36(6), 834-840. [More Information]
  • Martin, D., Hruby, G., Whitaker, M., Foo, K. (2012). Constrained-beam inverse planning for intensity-modulated radiation therapy of prostate cancer patients with bilateral hip prostheses. Journal of Medical Imaging and Radiation Oncology, 56(6), 703-707. [More Information]
  • Hardcastle, N., Tome, W., Foo, K., Miller, A., Carolan, M., Metcalfe, P. (2011). Comparison of prostate imrt and vmat biologically optimised treatment plans. Medical Dosimetry, 36(3), 292-298. [More Information]
  • Kelly, A., Hardcastle, N., Metcalfe, P., Cutajar, D., Quinn, A., Foo, K., Cardoso, M., Barlin, S., Rosenfeld, A. (2011). Surface dosimetry for breast radiotherapy in the presence of immobilization cast material. Physics in Medicine and Biology, 56(4), 1001-1013. [More Information]
  • Gulliford, S., Foo, K., Morgan, R., Aird, E., Bidmead, A., Critchley, H., Evans, P., Gianolini, S., Mayles, W., Moore, A., et al (2010). Dose-Volume Constraints to Reduce Rectal Side Effects From Prostate Radiotherapy: Evidence From MRC RT01 Trial ISRCTN 47772397. International Journal of Radiation: Oncology - Biology - Physics, 76(3), 747-754. [More Information]
  • Hardcastle, N., Davies, A., Foo, K., Miller, A., Metcalfe, P. (2010). Rectal dose reduction with IMRT for prostate radiotherapy. Journal of Medical Imaging and Radiation Oncology, 54(3), 235-248. [More Information]
  • Murthy, V., Thomas, K., Foo, K., Cunningham, D., Johnson, B., Norman, A., Horwich, A. (2008). Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy in Advanced Lymphoma: A Phase II Study. Clinical Lymphoma, Myeloma and Leukemia, 8(4), 241-245. [More Information]
  • Gebski, V., Burmeister, B., Smithers, B., Foo, K., Zalcberg, J., Simes, R. (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncology, 8(3), 226-234. [More Information]
  • Mangar, S., Foo, K., Norman, A., Khoo, V., Shahidi, M., Dearnaley, D., Horwich, A., Huddart, R. (2006). Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer. Clinical Oncology, 18(6), 466-473. [More Information]
  • Foo, K., Gebski, V., Yeghiaian-Alvandi, R., Foroudi, F., Vachan, B. (2005). Outcome following radiotherapy for loco-regionally recurrent non-small cell lung cancer. Journal of Medical Imaging and Radiation Oncology, 49(2), 108-112. [More Information]

2014

  • Ebert, M., Foo, K., Haworth, A., Gulliford, S., Kearvall, R., Kennedy, A., Richardson, S., Krawiec, M., Stewart, N., Joseph, D., et al (2014). Derivation and representation of dose-volume response from large clinical trial data sets: An example from the RADAR prostate radiotherapy trial. Journal of Physics: Conference Series, 489(1), Article number 012090. [More Information]
  • Ch'ng, S., Oates, J., Gao, K., Foo, K., Davies, S., Brunner, M., Clark, J. (2014). Prospective quality of life assessment between treatment groups for oral cavity squamous cell carcinoma. Head and Neck, 36(6), 834-840. [More Information]

2012

  • Martin, D., Hruby, G., Whitaker, M., Foo, K. (2012). Constrained-beam inverse planning for intensity-modulated radiation therapy of prostate cancer patients with bilateral hip prostheses. Journal of Medical Imaging and Radiation Oncology, 56(6), 703-707. [More Information]

2011

  • Hardcastle, N., Tome, W., Foo, K., Miller, A., Carolan, M., Metcalfe, P. (2011). Comparison of prostate imrt and vmat biologically optimised treatment plans. Medical Dosimetry, 36(3), 292-298. [More Information]
  • Kelly, A., Hardcastle, N., Metcalfe, P., Cutajar, D., Quinn, A., Foo, K., Cardoso, M., Barlin, S., Rosenfeld, A. (2011). Surface dosimetry for breast radiotherapy in the presence of immobilization cast material. Physics in Medicine and Biology, 56(4), 1001-1013. [More Information]

2010

  • Gulliford, S., Foo, K., Morgan, R., Aird, E., Bidmead, A., Critchley, H., Evans, P., Gianolini, S., Mayles, W., Moore, A., et al (2010). Dose-Volume Constraints to Reduce Rectal Side Effects From Prostate Radiotherapy: Evidence From MRC RT01 Trial ISRCTN 47772397. International Journal of Radiation: Oncology - Biology - Physics, 76(3), 747-754. [More Information]
  • Hardcastle, N., Davies, A., Foo, K., Miller, A., Metcalfe, P. (2010). Rectal dose reduction with IMRT for prostate radiotherapy. Journal of Medical Imaging and Radiation Oncology, 54(3), 235-248. [More Information]

2008

  • Murthy, V., Thomas, K., Foo, K., Cunningham, D., Johnson, B., Norman, A., Horwich, A. (2008). Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy in Advanced Lymphoma: A Phase II Study. Clinical Lymphoma, Myeloma and Leukemia, 8(4), 241-245. [More Information]

2007

  • Gebski, V., Burmeister, B., Smithers, B., Foo, K., Zalcberg, J., Simes, R. (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncology, 8(3), 226-234. [More Information]

2006

  • Mangar, S., Foo, K., Norman, A., Khoo, V., Shahidi, M., Dearnaley, D., Horwich, A., Huddart, R. (2006). Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer. Clinical Oncology, 18(6), 466-473. [More Information]

2005

  • Foo, K., Gebski, V., Yeghiaian-Alvandi, R., Foroudi, F., Vachan, B. (2005). Outcome following radiotherapy for loco-regionally recurrent non-small cell lung cancer. Journal of Medical Imaging and Radiation Oncology, 49(2), 108-112. [More Information]

To update your profile click here. For support on your academic profile contact .